Gobiga Vanniyasingam

FDA investigator

Appears on 4 documents from 2018 to 2019, mostly at sites in New Jersey. Most often cites corrective and preventive action (21 CFR 820.100(a)).

4
Documents on file
5.5
Observations per 483
2018
First seen
2019
Most recent

What they cite most

From 22 observations

Activity by year

2018: 1, 2019: 3

Where

New Jersey 4

Is Gobiga Vanniyasingam coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Lingraphicare America, Inc. 103 Carnegie Ctr Ste 104Nov 15, 2019 · Princeton, New Jersey
483 Pharmaceutical Innovations, IncMay 29, 2019 · Newark, New Jersey
483 TERRIFIC CARE LLCFeb 5, 2019 · Passaic, New Jersey
483 Replication Medical, IncAug 22, 2018 · Monmouth Junction, New Jersey

About this profile

What does Gobiga Vanniyasingam inspect?

Gobiga Vanniyasingam appears on 4 documents on file covering 4 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 820.100(a) (corrective and preventive action), followed by 21 CFR 820.181 and 21 CFR 820.184.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gobiga Vanniyasingam is dated Nov 15, 2019.